Clinical trials
Recruiting Observational Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Photocure | 2 |
| Association Francaise d'Urologie | 1 |
| Convergent Genomics, Inc. | 1 |
| IRCCS San Raffaele | 1 |
| Janssen Research & Development, LLC | 1 |
| Johns Hopkins University | 1 |
| Jørgen Bjerggaard Jensen | 1 |
| Natera, Inc. | 1 |
| Oslo University Hospital | 1 |
| Peking University First Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 16 |
| Urinary Bladder Neoplasms | 10 |
| Carcinoma, Transitional Cell | 2 |
| Recurrence | 2 |
| Disease Progression | 1 |
| Hematuria | 1 |
| Urinary Bladder Diseases | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.